Comirnaty (Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Comirnaty (Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine), covering 2024-09-20 to 2024-09-20. Get the full timeline:
Most recent: Clinical Trial Update: This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.